Study for the aim of gene therapy of nasopharyngeal carcinoma
Study for the aim of gene therapy of nasopharyngeal carcinoma
批准号:
10470353
负责人:
FURUKAWA Mitsuru
金额:
$7.36万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nasopharyngeal carcinoma (NPC), an epithelial tumor which is characterized by marked geographic and population differences in incidence, is found to be associated with Epstein-Barr virus (EBV) by serologic evidence, and the relationship was confirmed by the detection of EBVDNA and EB-encoded RNAs in NPC cells. While, NPC is highly metastatic carcinoma whose consistent associated with EBV has been established. Latent membrane protein 1 (LMP1), an EBV membrane protein expressed in latent infection is considered to be the EBV oncoprotein. Matrix metalloproteinase 9 (MMP9), one of the MMP families, degrades Type IVcollagen, a major 4 component of extracellural matrix and is believed to be crucial for cancer invasion and metastasis. Although MMP9 is reported to be expressed in a variety of cancers, no reports concerning NPC have been published. We have shown that LMP1 induces MMP9 in vitro cell line, which suggests the possibility of mechanism in which LMP1 of EBV contributes to the metasta … More sis and tumorgenesis of NPC by the induction of MMP9. Then the expression of LMP1 and MMP9 were immunohistochemically examined in 38 NPCs sections, and the relation of these proteins was statistically analyzed. We also analyzed the association of these proteins with clinical features. As results, both LMP1 and MMP9 proteins were predominantly immunolocalized in cancer nests. The expression of MMP9 showed a significant positive correlation with the expression of LMP1. Also the expression of MMP9 correlated with lymphnode metastasis.We also demonstrated that LMP1 enhances MMP9 expression by activation of nuclear factor ( NF) κ B and activator protein (AP)-1 . We therefore tested whether upregulation of MMP9 by LMP1 could be correlated with enhanced invasiveness of tumor cells in vitro. Whether aspirin and sodium salicylate could reduce invasiveness and whether LMP1 could enhance MMP9 expression in tumors grown in nude mice were also tested. C33A cells stably expressing LMP1 had increased expression of MMP9 and showed greater invasion through reconstituted basement membrane compared with vector-transfected C33A cells. Treatment with aspirin and sodium salicylate inhibited invasiveness of the LMP1-expressing C33A cells and suppressed both the LMP1-induced MMP9expewssion in zymographic analyses and LMP1-induced MMP9 promoter activity in CAT reporter assays. The inhibitory effect of aspirin on NF- κ B activity was attributable to the inhibition of l-κ B kinase activity. Finally, tumors derived from vector-transfected C33A cells stably expressing LMP1 grown in nude mice showed enhanced MMP9 levels compared with tumors derived from vector-trancfected C33A cells. This enhancement was inhibited by treatment of the mice with aspirin. These results suggest that aspirin may be able to suppress invasion and metastasis of EBV-associated tumors that express LMP1 by suppression of MMP-9. Less
期刊论文(110)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
吉崎智一: "転移の分子機構"JOHNS. 16(4). 559-562 (2000)
Tomokazu Yoshizaki:“转移的分子机制”JOHNS 16(4)(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Yoshizaki, H.Sato, S.Murono, J.S.Pagano, M.Furukawa: "Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator."Clinical and Experimental Metastasis. 17. 431-436 (1999)
T.Yoshizaki、H.Sato、S.Murono、J.S.Pagano、M.Furukawa:“基质金属蛋白酶 9 由 Epstein-Barr 病毒 BZLF1 反式激活因子诱导。”临床和实验转移。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Yoshizaki., H.Miwa., H.Takeshita., H.Sato., M.Furukawa: "Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLE1 in nasopharyngeal carcinoma"Cancer Res Clin Oncol. 126. 69-73 (2000)
T.Yoshizaki.、H.Miwa.、H.Takeshita.、H.Sato.、M.Furukawa:“鼻咽癌中针对 Epstein-Barr 病毒基因 BRLF1 和 BZLE1 的抗体升高”Cancer Res Clin Oncol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
古川仞: "新図解耳鼻咽喉科・頭頚部外科講座 第5巻頭頚部腫瘍"メジカル・ビュー社. 6 (2001)
古川:《新图解耳鼻喉科/头颈外科教程第5卷头颈肿瘤》Medical View Publishing 6 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
吉崎 智一他: "上咽頭癌転移とcollagenase,血管新生,LMP1との関連" JOHNS. 14(11). 1631-1634 (1998)
Tomokazu Yoshizaki 等人:“鼻咽癌转移与胶原酶、血管生成和 LMP1 之间的关系”JOHNS 14(11) 1631-1634 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 46 条
Identification and cell line establishment of human osteoclast precursor cell
-
批准号:22591690
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:FURUKAWA Mitsuru
-
依托单位:
Analysis of IL-27 receptor deficient mouse induced by inflammatory bone destruction model
-
批准号:20791055
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2008
-
负责人:FURUKAWA Mitsuru
-
依托单位:
Molecular biological analysis of Siah1 in EBV related tumor including nasopharyngeal cancer
-
批准号:19390433
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2007
-
负责人:FURUKAWA Mitsuru
-
依托单位:
The relationship between single nucleotide polymorphism of matrix metallopraeinase-1 and metastasis of nasopharyngeal carcinoma.
-
批准号:16390487
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:2004
-
负责人:FURUKAWA Mitsuru
-
依托单位:
Molecular, biological studies on the mechanism of neck metastasis from nasopharyngeal carcinoma
-
批准号:13470358
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.55万
-
财政年份:2001
-
负责人:FURUKAWA Mitsuru
-
依托单位:
Quantitative analysis of Epstein-Barr virus immediate-early proteins and evaluation of its clinical role especially in nasopharyngeal
-
批准号:08457450
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.93万
-
财政年份:1996
-
负责人:FURUKAWA Mitsuru
-
依托单位:
Detection of Epstein-Barr virus gene products, p53 protein and bcl-2 protein in nasopharyngeal carcinoma.
-
批准号:06454485
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.33万
-
财政年份:1994
-
负责人:FURUKAWA Mitsuru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
EB病毒核抗原1通过靶向PPP1CA稳定自身表达及其调控EBV潜伏感染的作用和机制研究
-
批准号:2026JJ50144
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢建红
-
依托单位:
EBV-RBM4通过稳定HOXB13 mRNA促进鼻咽癌细胞上皮-间质转化及恶性进展
-
批准号:2026JJ81710
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈志
-
依托单位:
EBV上调E3连接酶RNF114抑制鼻咽癌细胞Necroptosis机制研究
-
批准号:2026JJ81963
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘文斌
-
依托单位:
EBV-miR-BART19-3p抑制GADD45B增强cyclinB1/CDK1结合促进EBV相关胃癌细胞增殖的机制研究
-
批准号:2025JJ81046
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:阳静
-
依托单位:
聚合物分子刷激动剂调控三级淋巴组织丰度预防 EBV感染
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于VSV的新型多价EBV疫苗研发及保护
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:孔祥炜
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
EBV诱导鼻咽癌免疫治疗抵抗的作用及其
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:杨琦
-
依托单位:
PI3K 抑制剂抑制EBV阳性淋巴瘤的分子机制研究
-
批准号:JCZRLH202500224
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Vdelta2-T细胞外泌体疫苗携带IFN-gamma和TNF-alpha诱导抗原提呈细胞成熟并促进EBV肿瘤免疫应答的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王系伟
-
依托单位: